Search all trials

Find therapies in clinical trials near you – page 2

Search by disease and location to discover available clinical trials matching your criteria. Updated every day from authoritative EU registries.

recruiting: 3 962
countries: 28
conditions: 2 101

3 962 trials recruiting28 European countries2 101 conditions coveredUpdated today

Quick filters

Chronic graft versus host disease

Recruiting

Registered drug

Study on Axatilimab and Corticosteroids for Initial Treatment of Chronic Graft-Versus-Host Disease in Patients

Registered drug

Italy

Participants:0–17 years · 18–64 years · 65+ years
Substances:Axatilimab

Contact Research Centre

Hairy cell leukaemia

Recruiting

Registered drugNo placebo

Study of Vemurafenib and Rituximab for Untreated Hairy Cell Leukemia Patients

Registered drugNo placebo

Italy

Participants:18–64 years · 65+ years
Substances:Cladribine

Contact Research Centre

Chronic lymphocytic leukaemia

Recruiting

Registered drugNo placebo

Study of Ibrutinib for Treating Autoimmune Hemolytic Anemia in Patients with Chronic Lymphocytic Leukemia or Similar Conditions

Registered drugNo placebo

Italy

Participants:18–64 years · 65+ years
Substances:Ibrutinib

Contact Research Centre

Myelodysplastic syndrome

Recruiting

Registered drugNo placebo

Study of Azacitidine and Drug Combination Before Stem Cell Transplantation in Patients with High-Risk Myelodysplastic Syndrome

Registered drugNo placebo

Italy

Participants:18–64 years · 65+ years
Substances:Azacitidine

Contact Research Centre

Acute myeloid leukaemia

Recruiting

Investigational

Study on Mocravimod for Adults with Acute Myeloid Leukemia Undergoing Stem Cell Transplant

Investigational

Italy

Participants:18–64 years · 65+ years
Substances:Mocravimod

Contact Research Centre

Anaemia+4

Recruiting

Registered drugNo placebo

Study on Long-Term Safety of Luspatercept for Patients with Myelodysplastic Syndrome, Beta-Thalassemia, or Myelofibrosis Who Previously Participated in Luspatercept Trials

Registered drugNo placebo

Italy

Participants:18–64 years · 65+ years
Substances:Luspatercept

Contact Research Centre

Polycythaemia vera

Recruiting

Registered drugNo placebo

Study Comparing Givinostat and Hydroxyurea for Patients with High-Risk Polycythemia Vera

Registered drugNo placebo

Italy

Participants:18–64 years · 65+ years
Substances:Carbasalate Calcium

Contact Research Centre

Indolent systemic mastocytosis

Recruiting

Investigational

Study of TL-895 for Patients with Relapsed or Refractory Myelofibrosis or Indolent Systemic Mastocytosis

Investigational

Italy

Participants:18–64 years · 65+ years
Substances:1-4-{[6-Amino-5-(4-Phenoxy-Phenyl)-Pyrimidin-4-Ylamino]-Methyl}-4-Fluoro-Piperidin-1-Yl)-Propenone

Contact Research Centre

Chronic lymphocytic leukaemia

Recruiting

Registered drugNo placebo

Study of venetoclax, obinutuzumab and zanubrutinib combination therapy in young patients with high-risk Chronic Lymphocytic Leukemia and residual disease

Registered drugNo placebo

Italy

Participants:18–64 years
Substances:Allopurinol

Contact Research Centre

Acute myeloid leukaemia

Recruiting

Registered drugNo placebo

Study on Early Treatment Intensification for Acute Myeloid Leukemia with FLT3 Mutation Using Cytarabine, Midostaurin, and Daunorubicin Hydrochloride for Patients with Low Chemosensitivity

Registered drugNo placebo

Italy

Participants:18–64 years · 65+ years
Substances:Cytarabine

Contact Research Centre

Chronic graft versus host disease

Not yet recruiting

Registered drugNo placebo

Study of belumosudil versus drug combination in patients aged 12 years and older with chronic graft‑versus‑host disease refractory after prior therapy

Registered drugNo placebo

Italy

Participants:0–17 years · 18–64 years · 65+ years
Substances:Bortezomib

Contact Research Centre

Graft versus host disease

Not yet recruiting

InvestigationalNo placebo

A study to evaluate the effectiveness of MC0518 (mesenchymal stromal cells) in adults with acute graft-versus-host disease that has not responded to steroids and ruxolitinib

InvestigationalNo placebo

Italy

Participants:18–64 years · 65+ years
Substances:Mesenchymal Stromal Cells, Ex Vivo Cultured

Contact Research Centre

Find therapies in clinical trials near you – page 2

67 trials match your criteria

Chronic graft versus host disease

Study on Axatilimab and Corticosteroids for Initial Treatment of Chronic Graft-Versus-Host Disease in Patients

Hairy cell leukaemia

Study of Vemurafenib and Rituximab for Untreated Hairy Cell Leukemia Patients

Chronic lymphocytic leukaemia

Study of Ibrutinib for Treating Autoimmune Hemolytic Anemia in Patients with Chronic Lymphocytic Leukemia or Similar Conditions

Myelodysplastic syndrome

Study of Azacitidine and Drug Combination Before Stem Cell Transplantation in Patients with High-Risk Myelodysplastic Syndrome

Acute myeloid leukaemia

Study on Mocravimod for Adults with Acute Myeloid Leukemia Undergoing Stem Cell Transplant

Anaemia+4

Study on Long-Term Safety of Luspatercept for Patients with Myelodysplastic Syndrome, Beta-Thalassemia, or Myelofibrosis Who Previously Participated in Luspatercept Trials

Polycythaemia vera

Study Comparing Givinostat and Hydroxyurea for Patients with High-Risk Polycythemia Vera

Indolent systemic mastocytosis

Study of TL-895 for Patients with Relapsed or Refractory Myelofibrosis or Indolent Systemic Mastocytosis

Chronic lymphocytic leukaemia

Study of venetoclax, obinutuzumab and zanubrutinib combination therapy in young patients with high-risk Chronic Lymphocytic Leukemia and residual disease

Acute myeloid leukaemia

Study on Early Treatment Intensification for Acute Myeloid Leukemia with FLT3 Mutation Using Cytarabine, Midostaurin, and Daunorubicin Hydrochloride for Patients with Low Chemosensitivity

Chronic graft versus host disease

Study of belumosudil versus drug combination in patients aged 12 years and older with chronic graft‑versus‑host disease refractory after prior therapy

Graft versus host disease

A study to evaluate the effectiveness of MC0518 (mesenchymal stromal cells) in adults with acute graft-versus-host disease that has not responded to steroids and ruxolitinib

Explore other searches

Vaccine trials

Paediatric trials · ages 0–17

Healthy volunteers

Helpful resources

How applying through us works

What happens after you apply

Guides for patients and volunteers

Search filters

Prefer not to search? Our Concierge searches the trials for you.